Terns Pharmaceuticals
TERN
TERN
112 hedge funds and large institutions have $415M invested in Terns Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 36 increasing their positions, 34 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less capital invested
Capital invested by funds: $424M → $415M (-$9.03M)
7.86% less ownership
Funds ownership: 105.68% → 97.82% (-7.9%)
Holders
112
Holding in Top 10
1
Calls
$1.16M
Puts
$362K
Top Buyers
| 1 | +$19.2M | |
| 2 | +$14.6M | |
| 3 | +$9.47M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$5.17M |
| 5 |
OCA
Octagon Capital Advisors
New York
|
+$4.1M |
Top Sellers
| 1 | -$29.3M | |
| 2 | -$18.8M | |
| 3 | -$15M | |
| 4 |
VA
VR Adviser
New York
|
-$7.13M |
| 5 |
PA
Perceptive Advisors
New York
|
-$6.98M |